Latest News

Date Title Topic
28 Sep 2014 ESMO 2014 Press Release: MAGRIT Phase III Trial Results Raise Questions About the Future of Lung Cancer Vaccination Lung and other thoracic tumours - Immuno-oncology
28 Sep 2014 ESMO 2014: Bevacizumab Maintenance in HER2-Negative Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 The Promise of Tumour-Infiltrating Lymphocytes for Cancer Treatment and as Prognostic/Predictive Indicators Breast cancer - Immuno-oncology
28 Sep 2014 How an Understanding of Melanoma Development is Changing the Clinical Landscape of its Treatment Melanoma
28 Sep 2014 ESMO 2014 Press Release: Many Patients Lack Information About the Use of Targeted Therapies, Oncologists Say Bioethics, legal and economic issues
28 Sep 2014 ESMO 2014 Press Release: Significant Presence of Women in Oncology, but Still Under-Representation in Leadership Positions, Greek Survey Shows Bioethics, legal and economic issues
28 Sep 2014 Metastatic NSCLC: New Findings, New Avenues to Explore Lung and other thoracic tumours
28 Sep 2014 Pathway of the Day: Hedgehog Pathology/Molecular biology
28 Sep 2014 ESMO 2014: Second-Line Targeted Treatments in Patients with Advanced Hepatocellular Carcinoma Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Adding Cediranib to Chemotherapy Improves Progression-Free Survival for Metastatic or Recurrent Cervical Cancer, Phase II Trial Shows Gynaecologic malignancies - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: Pertuzumab Adds 16 Months Survival Benefit to Trastuzumab and Chemotherapy Treatment for HER2-Positive Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
28 Sep 2014 ESMO 2014 Press Release: IMPRESS Trial Data on Continuing Tyrosine Kinase Inhibitor Therapy After Resistance Development in Lung Cancer Reported Lung and other thoracic tumours - Anticancer agents & Biologic therapy
Photo Reportage
27 Sep 2014 ESMO 2014: How to Guide the Selection of Chemotherapy Regimen for Non-Squamous Non-Small Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: Results of LUX-Lung 8, the Largest Prospective Trial to Compare EGFR TKIs in Patients with Relapsed/Refractory Squamous Cell Carcinoma of the Lung Lung and other thoracic tumours - Anticancer agents & Biologic therapy